PDS Planning’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$182K	Buy	50,000 +5,000	+11%	+$18.2K	0.01%	489
2025 Q1	$86.4K	Buy	45,000 +30,000	+200%	+$57.6K	0.01%	458
2024 Q4	$28.5K	Buy	+15,000	New	+$28.5K	﹤0.01%	442